Back to search

Article

Comparative real-world retention rate and safety of Biosimilar IBI303 versus Humira in Ankylosing Spondylitis

2024-07-29

Abstract excerpt

<title>Abstract</title> <p>OBJECTIVE Biosimilars play an important role in reducing the economic burden on patients, but the effectiveness of biosimilars in real-world is also being challenged, Therefore, we evaluated Humira and IBI303 for ankylosing spondylitis by retention rate and safety through real-world data. METHODS We extracted patient information from the hospital information system of Shenzhen Luohu P...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3802e529-b58f-51b4-aeae-00a0430e443b
DOI
10.21203/rs.3.rs-4676776/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative real-world retention rate and safety of Biosimilar IBI303 versus Humira in Ankylosing SpondylitisDOI 10.21203/rs.3.rs-4676776/v1
The importance of real-world data in evaluating the safety of biosimilars: a descriptive study of clinical practice in an oncohematological population.Semantic proximity
Biologic retention rate and efficacy in patients with cluster-based phenotypes of ankylosing spondylitis: data from a Korean national biologics registry.Semantic proximity
Continuous effectiveness and safety after a hospital-wide switch to adalimumab biosimilar: an observational study in rheumatoid arthritis patientsSemantic proximity
Differential long-term retention of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by age group from the FIRST registrySemantic proximity
Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registriesSemantic proximity
Fostering healthcare system sustainability through efficient practices: Can adopting biosimilars ease the financial burden of rheumatoid arthritis?Semantic proximity
Fostering healthcare system sustainability through efficient practices: Can adopting biosimilars ease the financial burden of rheumatoid arthritis?Semantic proximity
Efficacy And Safety of Wenbu Zhibi Granule In Patients With Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialSemantic proximity
Molecular Biosimilarity--A Paradigm ShiftSemantic proximity
Genetic polymorphisms of FcGR2B and adalimumab effectiveness in Colombian patients with rheumatoid arthritis. Cases-controls studySemantic proximity
Evaluating the economic impact of eculizumab biosimilars in GermanySemantic proximity
Concomitant Sjögren’s disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss Clinical Quality Management cohortSemantic proximity
Select a neighboring publication to make it the new centre.